← All candidates
1 insider filing on record.
16 filings on record.
ARCTArcturus Therapeutics Holdings Inc.
NasdaqGM · Healthcare · $198.11M
$6.97
-2.65% · Jul 10
1 insider filing on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 buy◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ARCT ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$198.11M
Float
26.2M
92% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
3.6
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Financial Officer
Sassine Andy
Bought $20.5K on Aug 15 — 1,238 sh @ $16.56, held direct, 0.6% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$19.89 avg target
+185.3% vs today · 9 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
16 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice